CEFACLOR CAPSULES DIN 02237729
Health Canada record
| Active ingredient(s) | CEFACLOR 250 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01DC04 CEFACLOR |
| Original market date | 14-Jul-1998 |
| Current status date | 08-Nov-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Ivax Pharmaceuticals UK — licence , not currently licensed, last inspection rating C (2014-09-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CEFACLOR
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02230264 | APO-CEFACLOR | APOTEX INC | Capsule | CEFACLOR 500 MG | Cancelled Post Market |
| 02237502 | APO-CEFACLOR | APOTEX INC | Powder | CEFACLOR 375 MG | Cancelled Post Market |
| 02237500 | APO-CEFACLOR | APOTEX INC | Powder | CEFACLOR 125 MG | Cancelled Post Market |
| 02237501 | APO-CEFACLOR | APOTEX INC | Powder | CEFACLOR 250 MG | Cancelled Post Market |
| 02230263 | APO-CEFACLOR | APOTEX INC | Capsule | CEFACLOR 250 MG | Cancelled Post Market |
| 00465186 | CECLOR | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Capsule | CEFACLOR 250 MG | Cancelled Post Market |
| 00465194 | CECLOR | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Capsule | CEFACLOR 500 MG | Cancelled Post Market |
| 00465208 | CECLOR | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Powder For Suspension | CEFACLOR 125 MG | Cancelled Post Market |
| 00465216 | CECLOR | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Powder For Suspension | CEFACLOR 250 MG | Cancelled Post Market |
| 00832804 | CECLOR | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Powder For Suspension | CEFACLOR 375 MG | Cancelled Post Market |
| 02237381 | CEFACLOR | MM THERAPEUTICS INC | Capsule | CEFACLOR 500 MG | Cancelled Post Market |
| 02237380 | CEFACLOR | MM THERAPEUTICS INC | Capsule | CEFACLOR 250 MG | Cancelled Post Market |
| 02237382 | CEFACLOR | MM THERAPEUTICS INC | Suspension | CEFACLOR 125 MG | Cancelled Post Market |
| 02237383 | CEFACLOR | MM THERAPEUTICS INC | Suspension | CEFACLOR 250 MG | Cancelled Post Market |
| 02237384 | CEFACLOR | MM THERAPEUTICS INC | Suspension | CEFACLOR 375 MG | Cancelled Post Market |
| 02237730 | CEFACLOR CAPSULES | IVAX PHARMACEUTICALS INCORPORATED | Capsule | CEFACLOR 500 MG | Cancelled Post Market |
| 02238791 | CEFACLOR SUSPENSION | IVAX PHARMACEUTICALS INCORPORATED | Powder For Suspension | CEFACLOR 187 MG | Cancelled Pre Market |
| 02238793 | CEFACLOR SUSPENSION | IVAX PHARMACEUTICALS INCORPORATED | Powder For Suspension | CEFACLOR 375 MG | Cancelled Pre Market |
| 02238790 | CEFACLOR SUSPENSION | IVAX PHARMACEUTICALS INCORPORATED | Powder For Suspension | CEFACLOR 125 MG | Cancelled Pre Market |
| 02238792 | CEFACLOR SUSPENSION | IVAX PHARMACEUTICALS INCORPORATED | Powder For Suspension | CEFACLOR 250 MG | Cancelled Pre Market |
| 02238202 | CEFACLOR-125 | PRO DOC LIMITEE | Powder | CEFACLOR 125 MG | Cancelled Post Market |
| 02238203 | CEFACLOR-250 | PRO DOC LIMITEE | Powder | CEFACLOR 250 MG | Cancelled Post Market |
| 02238200 | CEFACLOR-250 | PRO DOC LIMITEE | Capsule | CEFACLOR 250 MG | Cancelled Post Market |
| 02238204 | CEFACLOR-375 | PRO DOC LIMITEE | Powder | CEFACLOR 375 MG | Cancelled Post Market |
| 02238201 | CEFACLOR-500 | PRO DOC LIMITEE | Capsule | CEFACLOR 500 MG | Cancelled Post Market |
| 02177668 | DOM-CEFACLOR 125 - SUS 25MG/ML | DOMINION PHARMACAL | Suspension | CEFACLOR 25 MG | Cancelled Post Market |
| 02177676 | DOM-CEFACLOR 250-SUS 50MG/ML | DOMINION PHARMACAL | Suspension | CEFACLOR 50 MG | Cancelled Post Market |
| 02177684 | DOM-CEFACLOR 375 B.I.D. | DOMINION PHARMACAL | Suspension | CEFACLOR 75 MG | Cancelled Post Market |
| 02231693 | NOVO-CEFACLOR | TEVA CANADA LIMITED | Capsule | CEFACLOR 500 MG | Cancelled Post Market |
| 02231691 | NOVO-CEFACLOR | TEVA CANADA LIMITED | Capsule | CEFACLOR 250 MG | Cancelled Post Market |
| 02238051 | NU-CEFACLOR | NU-PHARM INC | Powder | CEFACLOR 375 MG | Cancelled (Unreturned Annual) |
| 02231433 | NU-CEFACLOR | NU-PHARM INC | Capsule | CEFACLOR 500 MG | Cancelled Post Market |
| 02238050 | NU-CEFACLOR | NU-PHARM INC | Powder | CEFACLOR 250 MG | Cancelled (Unreturned Annual) |
| 02238049 | NU-CEFACLOR | NU-PHARM INC | Powder | CEFACLOR 125 MG | Cancelled (Unreturned Annual) |
| 02231432 | NU-CEFACLOR CAPSULES 250MG | NU-PHARM INC | Capsule | CEFACLOR 250 MG | Cancelled Post Market |
| 02185830 | PMS-CEFACLOR | PHARMASCIENCE INC | Capsule | CEFACLOR 250 MG | Cancelled Post Market |
| 02185849 | PMS-CEFACLOR | PHARMASCIENCE INC | Capsule | CEFACLOR 500 MG | Cancelled Post Market |
| 02185857 | PMS-CEFACLOR 125 - PWS 25MG/ML | PHARMASCIENCE INC | Powder For Solution | CEFACLOR 25 MG | Cancelled Post Market |
| 02185865 | PMS-CEFACLOR 250 - PWS 50MG/ML | PHARMASCIENCE INC | Powder For Solution | CEFACLOR 50 MG | Cancelled Post Market |
| 02185873 | PMS-CEFACLOR 375 B.I.D. | PHARMASCIENCE INC | Powder For Solution | CEFACLOR 75 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 339 | 2002-11-08 | Abbreviated New Drug Submission (ANDS) | MANUFACTURER AND PRODUCT NAME CHANGE |
| 2787 | 1998-04-06 | Abbreviated New Drug Submission (ANDS) |
International API supply for CEFACLOR
5 valid EDQM Certificates of Suitability from 5 holders. 1 active FDA Drug Master Files.
Request a quote for CEFACLOR CAPSULES